Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 per share, targeting approximately $117.1 million in net proceeds. The offering was for $125 million of common stock.
Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 per share for gross proceeds of $125M, expected to close on or about Sept. 30, 2026, subject to customary conditions.Material DetailsContext by AI AnalystThis is a capital raise to fund ongoing development of NXC…